Thus, in this study, we aimed to determine whether IL-6 levels are associated with disease severity and mortality in COVID-19 patients and investigate whether dynamic changes in IL-6 levels are predictive of pulmonary lesions caused by ARDS in hospitalized COVID-19 patients. The gene discussed is IL6; the disease is acute respiratory distress syndrome.